Research Articles
Breaking the Code: A Novel Triple-Drug Strategy for Acute Myeloid Leukemia
Exploring the innovative Phase 1/2 study of CC-90011 combined with venetoclax and azacitidine for treating acute myeloid leukemia (AML)
Evolution of the Genomic Landscape in Acute Myeloid Leukemia after Decitabine and Venetoclax
Exploring how AML's genomic landscape evolves under decitabine and venetoclax treatment, including mutation clearance patterns, resistance mechanisms, and clinical implications.
When Promise Meets Reality: The Story of Ganetespib and the Fight Against AML
An in-depth analysis of the LI-1 Trial assessing Ganetespib combined with low-dose cytarabine for older patients with Acute Myeloid Leukaemia.